SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-24-000450
Filing Date
2024-01-03
Accepted
2024-01-03 17:01:48
Documents
2
Period of Report
2023-12-29

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1615
2 POA DOCUMENT poa.txt EX-24 3907
  Complete submission text file 0001209191-24-000450.txt   7249
Mailing Address 685 ROUTE 202/206 N., SUITE 301 BRIDGEWATER NJ 08807
Business Address 685 ROUTE 202/206 N., SUITE 301 BRIDGEWATER NJ 08807 800-775-7936
VYNE Therapeutics Inc. (Issuer) CIK: 0001566044 (see all company filings)

IRS No.: 453757789 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 685 ROUTE 202/206 N, SUITE 301 BRIDGEWATER NJ 08807
Business Address
Borowski Christine (Reporting) CIK: 0002005073 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38356 | Film No.: 24507886